-
Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diver...
International audience -
Mitochondrial abnormalities in patients with HIV-HCV co-infection as compared...
International audience -
Improvement in liver pathology of patients with β-thalassemia treated with de...
International audience -
Antiviral activity of danoprevir (ITMN-191/RG7227) in combination with pegyla...
International audience -
Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of p...
International audience -
Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polyt...
International audience -
Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor ...
International audience -
Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends...
International audience -
Hepatitis C virus infection may lead to slower emergence of P. falciparum in ...
International audience -
Cryofibrinogen in patients with hepatitis C virus infection.
International audience -
Recent contributions of in vitro models to our understanding of hepatitis C v...
International audience -
Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is med...
International audience -
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targ...
International audience -
Is routine viral screening useful in patients with recent-onset polyarthritis...
International audience -
Evolution of Hepatitis B and C serum markers: a still challenging issue.
International audience -
Infection with hepatitis B and C viruses and risk of lymphoid malignancies in...
International audience -
Prospects for prophylactic hepatitis C vaccines based on virus-like particles.
International audience -
PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 e...
International audience -
Novel HCV replication mouse model using human hepatocellular carcinoma xenogr...
In the absence of an immunocompetent mouse model for HCV replication, we developed a convenient xenograft mouse model that produces infectious viral particles. For... -
No increased mortality from donor or recipient hepatitis B- and/or hepatitis ...
International audience
